FRS2 and neoplasm: In order to evaluate the occurrence of activated FGFR2 signalling in the tumor tissue of iCCA patients with FGFR2 GAs, we assessed the levels of protein phosphorylation of both FGFR2 and FRS2α, its main downstream target.